REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Concord Drugs Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Concord Drugs Ltd. Profile Updated: December 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Concord Drugs is a pharmaceutical company based in Hyderabad, India. The company specializes in Tissue Bio-Adhesive, Dry Syrups, Ready to Fill Pellets & MUPS, Injectables, and Liquid Orals. They also manufacture Hand Sanitizers on a Third Party Basis. Concord Drugs uses modern equipment and technologies for their manufacturing operations and serves the pharma sector with a versatile product range.

Legal Address
Survey No.249,, , Brahmanpally Village
Hyderabad; Telangana; Postal Code: 501511

Contact Details: Purchase the Concord Drugs Ltd. report to view the information.

Website: http://www.concorddrugs.in

Basic Information
Total Employees:
Purchase the Concord Drugs Ltd. report to view the information.
Outstanding Shares:
Purchase the Concord Drugs Ltd. report to view the information.
Registered Capital:
Purchase the Concord Drugs Ltd. report to view the information.
Financial Auditors:
Purchase the Concord Drugs Ltd. report to view the information.
Incorporation Date:
March 07, 1995
Key Executives
Purchase this report to view the information.
Executive Director & CFO
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Non Executive Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
34.16%
Purchase this report to view the information.
28.61%
Purchase this report to view the information.
16.28%
Purchase this report to view the information.
9.51%
Purchase this report to view the information.
1.89%
Subsidiaries
Proton Remedies Private Limited
100%
Company Performance
Financial values in the chart are available after Concord Drugs Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.71%▼
Total operating revenue
-0.74%▼
Operating Profit/Loss (EBIT)
37.3%▲
EBITDA
23.82%▲
Net Profit/Loss for the Period
338.47%▲
Total Assets
-6.35%▼
Total Equity
1.58%▲
Operating Profit Margin (ROS)
1.63%▲
Net Profit Margin
1.01%▲
Return on Equity (ROE)
0.69%▲
Debt/Equity
-6.69%▼
Quick Ratio
-0.38%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo